Yibo Zhan Min Zhao Xiaojun Li Huiying Ouyang Chenghao Du Guixian Chen Zhenzhen Lou Haoxuan Chen Yuanqi Zhao Haoyou Xu
10.3389/fimmu.2023.1208017
Front Immunol
2023 Jun 28;14:1208017.
b cell depletion therapy neuromyelitis optica spectrum disorder ofatumumab refractory relapse
CC BY
https://pubmed.ncbi.nlm.nih.gov/37449206/
Neuromyelitis Optica / diagnosis Neuromyelitis Optica / drug therapy
Neuromyelitis Optica / diagnosis Neuromyelitis Optica / drug therapy Case Reports Adult Azathioprine / adverse effects Female Humans Immunosuppressive Agents / therapeutic use Treatment Outcome ofatumumab Immunosuppressive Agents Azathioprine
PMC10337780
37449206
A meaningful exploration of ofatumumab in refractory NMOSD: a case report
2023